JAC-AMR is our fully open-access journal dedicated to exploring all aspects of antimicrobial resistance. For a limited time only, BSAC Members will recieve 50% discount on the standard article processing charge (APC).

The International Society of Antimicrobial Chemotherapy (ISAC) is offering small project grants (£5000 - £10,000) to applicants from ISAC member societies.

BSAC is establishing a UK Drug Registry (UKAR) to provide prescribers and organisations the opportunity to capture real world usage of antimicrobial agents and identify where real clinical unmet needs lie. This will provide an invaluable resource for future research studies and also enable the sharing of best practice.

BSAC is delighted to be part of the Alliance for the Prudent Use of Antibiotics, now part of the International Society for Antimicrobial Chemotherapy.

BSAC has made three key recommendations in its response to the UK Parliament’s Health and Social Care Select Committee’s inquiry, “Delivering Core NHS and Care Services during the Pandemic and Beyond”

Following the Interagency Coordination Group’s (IACG) recommendation that the UN Secretary General should establish an Independent Panel on Evidence on Action Against Antimicrobial Resistance, an advisory group was established to develop draft Terms of Reference (ToR) for the Panel. Here is the British Society for Antimicrobial Chemotherapy’s (BSAC) response to that draft.

The British Society for Antimicrobial Chemotherapy (BSAC) has urged other companies and major donors to boost coronavirus (COVID-19) research and development after pharmaceutical company Pfizer awarded $1million to its grants programme.

Access to quality-assured laboratory diagnosis has long been a challenge in low-income and middle-income countries (LMICs) resulting in delayed or inaccurate diagnosis and ineffective treatment. But innovative approaches to design are helping to reduce the cost and availability of life-saving equipment...